FILTER

FILTERED INTERVIEW RESULTS

Gaurav Kaushik

MD AND CEO, METEORIC BIOPHARMACEUTICALS
"We have witnessed growing interest in utilizing plant-derived enzymes across various applications."

Saurabh Gurnurkar

MANAGING DIRECTOR, UQUIFA GROUP
"We can now initiate projects in Budapest and conclude them at our larger-scale GMP facility in Spain and/or Mexico, offering to our customers an option for integrated project management for their programs."

Tom Sellig

CEO, ADARE PHARMA SOLUTIONS
"There are hundreds of firms out there offering very specific services, and this will ultimately lead to more consolidation within the industry."

Victor Swint

CEO, FORMULATED SOLUTIONS
"Rather than merely facilitating tech transfers, we aspire to lead the innovation charge for our clients."

Bart van Berkel

CEO, CURTEC
"Since the establishment of our facility in the US, we have felt the appreciation of the market in being able to have a local partner, especially in light of many companies trying to localize their supply chains."

John Patrick Oroho

PRESIDENT AND GENERAL MANAGER, RLDATIX LIFE SCIENCES
"RLDatix is a one-stop-shop offering comprehensive solutions to navigate critical operational and compliance challenges in the life sciences industry."

Roger Erickson

CEO AND FOUNDER, INTERBIOME
"We have large and growing volumes of missing diagnostics and therapeutics that never even go through the pharma pipeline, not to mention the growing number of neglected products languishing in the development pipeline."

Subodh Deshmukh and Ramesh Subramanian

CEO BIOLOGICS AND PRESIDENT DEVELOPMENT (SD) AND CCO (RS), ARAGEN LIFE SCIENCES
"We further strengthened our drug product service offerings by adding clinical capacity to drug product manufacturing."

Kristof De Smedt and Amardeep Chahal

GLOBAL BUSINESS UNIT DIRECTOR (KS) AND SENIOR VP MARKETING CORPORATE DEVELOPMENT (AC), COLD CHAIN TECHNOLOGIES (CCT)
"By focusing on performance, cost-effectiveness, compliance, sustainability, and visibility, we help our pharmaceutical customers achieve the optimal balance in their thermal packaging solutions."

Peter Schiemann

CEO, YMMUNOBIO
"We are dedicated to establishing proof of concept with our ADC targeting NPTXR."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Southeast Asia Chemicals 2024

In an era of low-priced commodities and an uncertain geopolitical landscape, logistics companies are prioritizing the long-haul business, not just because it is probably the most profitable, but also because their customers are searching for new markets out to sea.

PARTNER EVENTS